Mobile

A study of nab-paclitaxel and gemcitabine with or without olaratumab for treatment of pancreatic cancer that has spread to other parts of the body

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-001099-31

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Phase Ib: To determine a recommended Phase 2 dose of olaratumab in combination with nab-paclitaxel and gemcitabine Phase II: To compare the efficacy of olaratumab plus nab-paclitaxel and gemcitabine with placebo plus gemcitabine and nab-paclitaxel

Critère d'inclusion

  • First-Line Metastatic Pancreatic Cancer

Liens